Table 6.

Serious Adverse Events: Total Patient Population, % of Patients

Placebo n=127500 mg Citicoline n=267
Death18%17%
Cardiovascular19%16%
Central nervous system11%19%
Respiratory12%13%
Gastrointestinal3%4%
Metabolic2%2%
Urologic1%5%
Heme/lymphatic1%2%
Musculoskeletal1%2%
Skin/appendages1%0%
Body as a whole9%9%